Acadesine

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAcadesine
Drug Alias Name阿卡地新acadesinum阿卡地辛Aica-ribosideacadesina +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsVentricular Dysfunction, LeftMyocardial InfarctionStroke +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFranceSpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvancell Advanced In Vitro Cell Technologies SaNational Center For Research ResourcesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsVentricular Dysfunction, LeftMyocardial InfarctionStroke +[5] 

Other Information

ATC CodeC01EB13
Related LinksWikipediaDrugBankKEGG